Abstract
A total of 161 Streptococcus pneumoniae were collected between 2013 and 2015 in Tehran, Iran. The strains were tested for antimicrobial susceptibility and minimum inhibitory concentrations, serotyped, and genotyped by multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE). Penicillin-binding proteins (PBPs) were also typed by restriction fragment length polymorphism (PBP-RFLP). Out of 161 strains, 32 isolates (20%) were highly resistant to penicillin. The most frequent serotypes among the penicillin-nonsusceptible S. pneumoniae (PNSP) were 14 (24%), 23F (18%), and 19F (17%). RFLP of pbp2b, pbp2x, and pbp1a genes revealed 8, 6, and 7 different patterns, respectively. Analysis of 93 PNSP isolates displayed 80 PFGE types with 8 common types constituting 21 (23%) isolates. The remaining 72 isolates (77%) were single types. MLST indicated a high degree of genetic diversity among the 93 PNSP with 36 different sequence types. Six internationally known penicillin resistant clones were identified in our isolates among which Spain23F-1 (ST81), Spain6B-2 (ST90), and Spain9V-3 (ST156) were the predominant clones. The results indicated international identifiable clones of S. pneumoniae, especially Spain23F-1 with high...Continue Reading
References
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P C Appelbaum
Aug 1, 1991·Molecular Microbiology·G LaibleR Hakenbeck
Aug 1, 1991·The Journal of Infectious Diseases·R MuñozB G Spratt
Jul 26, 1980·Lancet·M GrattenD Hansman
Mar 1, 1980·Antimicrobial Agents and Chemotherapy·R HakenbeckA Tomasz
Mar 1, 1995·FEMS Microbiology Letters·V A BarcusC G Dowson
Apr 1, 1996·Antimicrobial Agents and Chemotherapy·T Grebe, R Hakenbeck
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·A M Smith, K P Klugman
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·N MouzO Dideberg
Mar 9, 1999·The Journal of Infectious Diseases·M LouieA E Simor
May 1, 1999·Antimicrobial Agents and Chemotherapy·Y AsahiK Ubukata
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Kensuke NagaiPeter C Appelbaum
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Mignon du PlessisKeith P Klugman
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Estelle PaglieroAnne Marie Di Guilmi
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·K KosowskaP C Appelbaum
Nov 12, 2005·The Journal of Antimicrobial Chemotherapy·Dominic GrangerMichel Roger
Nov 21, 2007·PLoS Pathogens·Angela B BrueggemannBernard Beall
Dec 31, 2008·Journal of Bacteriology·Nicholas J CroucherTim J Mitchell
Feb 24, 2010·Pediatrics·Sheldon L KaplanEdward O Mason
Feb 24, 2011·Antimicrobial Agents and Chemotherapy·David TarragóAsunción Fenoll
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Juyoun ShinKwan Soo Ko
Jun 7, 2011·International Journal of Antimicrobial Agents·Göran KronvallGunnar Kahlmeter
Aug 30, 2011·Journal of Medical Microbiology·Bo ZhangBernard Beall
Mar 8, 2012·Future Microbiology·Regine HakenbeckPatrick Maurer
Jun 15, 2013·Emerging Infectious Diseases·Sandra S RichterGary V Doern
Jul 5, 2013·Journal of Global Health·Igor RudanHarry Campbell
May 24, 2014·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Leah J RicketsonJames D Kellner
Oct 3, 2014·Current Microbiology·J SadeghiM Talebi
Dec 3, 2014·Archives of Medical Research·Fernando HellmannSandra Caponi
May 29, 2015·The Pediatric Infectious Disease Journal·Anneke SteensDidrik F Vestrheim
Feb 26, 2016·Vaccines·Stanley S Tai
Dec 30, 2016·PloS One·Malihe TalebiMohammad R Pourshafie
Jan 8, 2017·The Journal of Biological Chemistry·Philippe CalvezAndré Zapun